2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92454°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

»çȸ¹®Á¦¸¦ ÇØ°áÇϴ û³â 478¸íÀÇ ¡®º£À̽ºÄ·ÇÁ¡¯°¡ µÇ´Ù

10³â°£ 478¸íÀÇ ¼ö·á»ý ¹èÃ⡦ ÀÓÆÑÆ® »ýŰè ÀÎÀç µî¿ë¹® ¿ªÇÒ
ºñ¿µ¸® »ç´Ü¹ýÀÎ ·çÆ®ÀÓÆÑÆ®°¡ ‘ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ(Impact Basecamp)’ ÇÁ·Î±×·¥ 10ÁÖ³âÀ» ¸Â¾Æ ¼ö·á»ýÀÇ º¯È­¿Í ÇÁ·Î±×·¥ÀÇ ¼º°ú¸¦ ´ãÀº ÀÓÆÑÆ® ¸®Æ÷Æ®¸¦ ¹ß°£ÇÏ°í ±â³äÇà»ç¸¦ °³ÃÖÇß´Ù. ÀÓÆÑÆ® º£À̽ºÄ·ÇÁ´Â û³âµéÀÌ »çȸ¹®Á¦¸¦ ÇØ°áÇÏ´Â ¿ª·®À» ±â¸£°í, À̸¦ Ä¿¸®¾î ¼ºÀå°ú ¿¬°èÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÏ´Â ±³À° ÇÁ·Î±×·¥ÀÌ´Ù. ¾à 8ÁÖ~16ÁÖ°£ »çȸ¹®Á¦¸¦ Á¤ÀÇÇϰí Á÷Á¢ ¹®Á¦ ÇØ°á ¹æ¹ýÀ» µµÃâÇÏ´Â ÇÁ·ÎÁ§Æ® ±â¹Ý ÇнÀ(Project Based Learning, PBL) ¹æ½ÄÀ¸·Î ÁøÇàµÈ´Ù. 2015³â ½ÃÀÛÇÑ ÀÌ·¡ ÇöÀç±îÁö 478¸íÀÇ ¼ö·á»ýÀ» ¹èÃâ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
Æ÷½ºÄÚÀÎÅͳ»¼Å³Î, º£Æ®³²¼­ ¡®ÆÁ½º´Ù¿î ¿ùµå¼î¡¯ °³ÃÖ (2024-06-01)
È¿¼ºÁß°ø¾÷ ¡®100% ¼ö¼Ò¿£Áø¹ßÀü±â¡¯ ¼¼°è ÃÖÃÊ »ó¿ëÈ­ (2024-05-26)
[Executive Corner] Achieving Meaningful Growth With ¡®Innova... (2024-05-26)
Wellness, Inclusive Camaraderie and Community Impact Take Ce... (2023-02-20)
À¯±â ¾ç±ØÀç ´ÜÁ¡ º¸¿ÏÇØ ¹èÅ͸® ¼º´É Çõ½ÅÀûÀ¸·Î Çâ»ó (2024-05-11)
ÇÑ»ù, ¼³ ¸íÀý °¡Á·¸ÂÀÌ ÇÒÀÎ Çà»ç (2023-01-15)
¾Ë¹Ù»ý 10¸í Áß 7¸í, ¡®¾Ë¹Ù ±¸Çϱ⠾î·Á¿ö¡¯ (2024-04-20)
LGÀüÀÚ, ¼¼°è ÃÖÃÊ µà¾ó¸ðµå ¿Ã·¹µå ¸ð´ÏÅÍ ½ÅÁ¦Ç° Ãâ½Ã (2024-04-20)
'IQ ¼¼°è 1À§' Çѱ¹ÀÎ ±è¿µÈÆ... ¿¬¼¼´ë ½ÅÇаú Ãâ½Å (2022-12-31)
ÀÏ·ë, »õÇб⠸ÂÀÌ ¡®½ÅÇб⠾ÆÀÌ¹æ ¾÷±×·¹À̵塯 (2022-12-28)
Newmont Completes $20 Million Global Community Support Fund,... (2024-04-11)
¡®ÀüÇö¹«°èȹ¡¯ ¸ÔÀß¾Ë ÁöÀÎ ÃßõÇÑ ¸ÀÁý ã¾Æ ¾È»ê±îÁö GO (2024-04-05)
The 3rd VINALAB and JAIMA Joint Symposium ¡°Water Quality - ... (2024-03-15)
Á¦·ÎÆäÀÌ, ¼Ò»ó°øÀÎ ¡®¿Ü±¹ÀÎ °ü±¤°´ ¸ÅÃ⡯ ±Þ¼ºÀå (2024-03-12)
Denodo Recognized as a Leader in Enterprise Data Fabric Eval... (2024-03-09)
¡®¾÷»çÀÌŬ °­»ç¾ç¼º°úÁ¤¡¯ Âü°¡ÀÚ ¸ðÁý (2024-03-09)
Perfect Moment Announces Closing of Initial Public Offering (2024-02-17)
ÀÚ±â°è¹ßÇü ¿¡¼¼ÀÌ ¡®µÚÅë¼ö - »ç¶÷À» ½±°Ô ¹ÏÁö ¸»¶ó!¡¯ (2024-01-18)
ÀΰøÁö´É ±â¹ÝÀ¸·Î ºÐÀÚ Æ¯¼º 1000¹è ºü¸¥ ¿¹Ãø ±â¼ú °³¹ß (2023-12-25)
¿ì¸®ÀºÇà, WON¹ðÅ· ¾Û Á¢¼Ó ÀÌ·Â µî ºÐ¼®ÇØ Æ¯È­¼­ºñ½º (2023-11-22)
Çѱ¹¼öÀÚ¿ø°ø»ç, ¹° ±â¾÷ ¾Æ½Ã¾Æ ÁøÃâ Áö¿ø (2023-11-19)
¿¡ÀÌ·£µå, 3.3 ÇÊµåÆ®¸³ X º£ÀÌÁ÷ÄÚÆ° Á¦Ç° Ãâ½Ã (2016-11-17)
Çö´ëÂ÷±×·ì, ¸ðºô¸®Æ¼ °³¹ßÀÚµéÀÇ ÃàÁ¦ 11¿ù °³ÃÖ (2023-10-17)
±â¾Æ ¼Û¿õ ¼±ÀÓ ¿ÀÅäÄÁ¼³ÅÏÆ®, 4õ´ë ÆÇ¸Å (2023-09-17)
¸ðµÎÅõ¾î ¡®³ª´Â ´ë¸¸Á· ÀÔ´Ï´Ù¡¯ ´ë¸¸ ±âȹÀü (2023-08-27)
       [ÀÌÀü][1]....[815][816][817][818][819][820][821][822][823]...[3699][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..